Trial Details
WITHDRAWNBasic Information
| Clinical ID | c172 |
|---|---|
| Identifier | NCT02463305 |
| Trial Title | Therapeutic Modulation of the Intestinal Creatine Kinase System in Inflammatory Bowel Disease (IBD) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Colitis, Ulcerative |
| Interventions | DRUG: Creatine monohydrate|OTHER: Placebo |
Participant Information
| Sponsor | University of Colorado, Denver |
|---|---|
| City | Denver |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | EARLY_PHASE1 |
Time Information
| Start Date | 2025-08-22 |
|---|---|
| Primary Completion Date | 2023-03-01 |
| Completion Date | 2023-03-01 |